Reproductive Genetic Testing
VCGS offers a comprehensive range of reproductive screening and diagnostic testing options with expert laboratory and clinical support. This means both patients and health professionals are fully supported.
percept™ non-invasive prenatal test includes assessment of all the chromosomes for identifying pregnancies at increased chance of having a chromosome condition.
prepair™ is a genetic carrier screen that gives individuals and couples information about their chance of having a child with a genetic condition.
Maternal serum screening is a blood test available to pregnant women who want to know their chance of having a baby with a chromosome condition, such as Down syndrome. Serum screening can also provide additional information about pregnancy health, such as the risk of developing early-onset pre-eclampsia.
Diagnostic testing for the identification of chromosome changes that affect normal fetal development and for the investigation of genetic causes of recurrent pregnancy loss and infertility.
Biochemical Genetics
Biochemical genetics involves the diagnosis, monitoring and treatment of metabolic conditions.
Newborn bloodspot screening is an extremely successful public health program which identifies babies that may have rare but significant medical conditions.
Metabolic disorders are a group of serious medical conditions caused by abnormal levels of metabolites in the blood or urine. This can be toxic and affect normal development.
Genetics and Genomics
VCGS provides a comprehensive range of specialist adult and childhood genetic tests and clinical services. Technologies include Next Generation Sequencing, SNP chromosome microarray, Sanger sequencing and MLPA.
Disorders/Differences of Sex Differentiation (DSD) are conditions where the development of chromosomal, anatomical or gonadal sex is atypical. DSD covers a wide spectrum of disorders such as hypospadias (misplacement of the urethral opening on the penis), premature ovarian insufficiency and complete sex reversal (where the physical sex does not match the genetic sex of an individual).
Clinical genomic sequencing is a powerful test that can help identify the cause of health and developmental problems. In many cases, clinical exome sequencing or whole genome sequencing (WGS) is used to seek answers for patients where other testing has failed to find a cause of their health problems.
The usefulness of genetic testing for degenerative neurogenetic conditions depends on the condition. While the genetic basis of some neurological conditions is well understood, the basis of others is not. Some of the more common neurogenetic conditions, such as Alzheimer disease or Parkinson disease, have subsets with a clear genetic cause, while the cause of other cases is unknown.
Identification of genetic causes of cardiac disorders can be lifesaving. Establishing a genetic cause for such conditions can affect further patient testing, management and surveillance. This information can also be important for immediate family members, who may be at risk of developing heart problems.
A chromosome microarray is a powerful tool used to look at genetic changes that affect health or development. Using high density SNP based technology allows for the identification of a larger number of genetic conditions.
Spinal Muscular Atrophy Carrier Screening
This test is a genetic screen to identify if you are a carrier of spinal muscular atrophy.
You must have a completed doctors request form to order this test online.
Cost
The cost of this test is AUD$220.00. No Medicare rebate available.
Spinal muscular atrophy carrier screening is available as a single test to order and pay online.
Cystic Fibrosis Carrier Screening & Diagnostic
This test is a genetic screen to identify if you are a carrier of cystic fibrosis and is available to order and pay online.
You must have a completed doctors request form to order this test.
Cost
The cost of this test is AUD$212.50.
Medicare eligibility
Patients may be eligible for a Medicare rebate, if:
Choose VCGS for comprehensive genetic testing and support services for a large range of single gene disorders including cystic fibrosis, fragile X syndrome, ataxias and hearing loss.
Mitochondria are known as our body's power plants. They burn the sugars, fats and proteins in our diet to generate the energy that our body needs to function normally. When our mitochondria don't function correctly this can impact our health.
VCGS provides a comprehensive range of diagnostic genetic testing for childhood cancers and has led the development of an advanced test for monitoring bone marrow and organ transplants.